PG6-13212-47876
2 vaccinations
3 coded responses
10 check-ins
3 free-text entries
9 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 800 / CO
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: RednessFree text: Soreness near injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-22
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-26
Health check-in — day 7, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-26
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-02-19
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-24
-
2022-01-09
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech |
Call center
9 call center cases
2 successful · 7 priority 2/3 (triaged and no follow up)
1 wait over 3 months for a first call
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Soreness near injection site
Release 4 — day 35, dose 2
Symptoms: Fatigue
Release 10 — 12 months, dose 2
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release